JP2024525870A5 - - Google Patents
Info
- Publication number
- JP2024525870A5 JP2024525870A5 JP2024502640A JP2024502640A JP2024525870A5 JP 2024525870 A5 JP2024525870 A5 JP 2024525870A5 JP 2024502640 A JP2024502640 A JP 2024502640A JP 2024502640 A JP2024502640 A JP 2024502640A JP 2024525870 A5 JP2024525870 A5 JP 2024525870A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antibody according
- day
- administered
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21186299.0 | 2021-07-19 | ||
| EP21186299 | 2021-07-19 | ||
| EP21203870 | 2021-10-21 | ||
| EP21203870.7 | 2021-10-21 | ||
| PCT/EP2022/070162 WO2023001804A1 (en) | 2021-07-19 | 2022-07-19 | Treatment of anti-pla2r autoantibody-mediated membranous nephropathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525870A JP2024525870A (ja) | 2024-07-12 |
| JP2024525870A5 true JP2024525870A5 (OSRAM) | 2025-07-17 |
Family
ID=82851755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502640A Pending JP2024525870A (ja) | 2021-07-19 | 2022-07-19 | 抗ｐｌａ２ｒ自己抗体媒介膜性腎症の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240343822A1 (OSRAM) |
| EP (1) | EP4373574A1 (OSRAM) |
| JP (1) | JP2024525870A (OSRAM) |
| KR (1) | KR20240035816A (OSRAM) |
| AU (1) | AU2022315512A1 (OSRAM) |
| CA (1) | CA3225908A1 (OSRAM) |
| CL (2) | CL2024000146A1 (OSRAM) |
| IL (1) | IL309940A (OSRAM) |
| MX (1) | MX2024000872A (OSRAM) |
| TW (1) | TW202321303A (OSRAM) |
| WO (1) | WO2023001804A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116535510B (zh) * | 2023-06-30 | 2023-11-10 | 四川省医学科学院·四川省人民医院 | 一种抗人pla2r的抗体、试剂盒及其应用 |
| WO2025254179A1 (en) * | 2024-06-06 | 2025-12-11 | Chugai Seiyaku Kabushiki Kaisha | Methods of using a bispecific antibody that recognizes coagulation factor ix and/or activated coagulation factor ix and coagulation factor x and/or activated coagulation factor x |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020164788A1 (en) | 1994-12-02 | 2002-11-07 | The Wellcome Foundation Limited | Humanized antibodies to CD38 |
| JP2003524587A (ja) | 1998-06-05 | 2003-08-19 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | 多発性骨髄腫を処置するための、ｃｄ３８に対する、遺伝子操作した抗体の使用 |
| US7223397B1 (en) | 1999-01-07 | 2007-05-29 | Research Development Foundation | Potentiation of anti-CD38-Immunotoxin cytotoxicity |
| EP1174440A1 (en) | 2000-07-19 | 2002-01-23 | U-BISys B.V. | A selectively-expressed epitope on the human CD38 molecule detected by a phage display library-derived human scFv antibody fragment |
| ES2541436T3 (es) | 2004-02-06 | 2015-07-20 | Morphosys Ag | Anticuerpos humanos anti-CD38 y usos para ellos |
| EP3312196B1 (en) | 2005-03-23 | 2019-07-17 | Genmab A/S | Antibodies against cd38 for treatment of multiple myeloma |
| EP1888647A2 (en) | 2005-05-24 | 2008-02-20 | MorphoSys AG | Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38 |
| PL2860192T3 (pl) | 2005-10-12 | 2018-03-30 | Morphosys Ag | Wytwarzanie i profilowanie w pełni ludzkich, uzyskanych z HuCAL GOLD terapeutycznych przeciwciał swoistych wobec ludzkiego CD38 |
| AU2007302448C1 (en) | 2006-09-26 | 2019-02-14 | Genmab A/S | Combination treatment of CD38-expressing tumors |
| EP1914242A1 (en) | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
| EP2191840A1 (en) | 2008-11-28 | 2010-06-02 | Sanofi-Aventis | Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan |
| EP2191842A1 (en) | 2008-11-28 | 2010-06-02 | Sanofi-Aventis | Antitumor combinations containing antibodies recognizing specifically CD38 and cytarabine |
| EP2191841A1 (en) | 2008-11-28 | 2010-06-02 | Sanofi-Aventis | Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine |
| EP2191843A1 (en) | 2008-11-28 | 2010-06-02 | Sanofi-Aventis | Antitumor combinations containing antibodies recognizing specifically CD38 and cyclophosphamide |
| JP7687956B2 (ja) * | 2019-03-15 | 2025-06-03 | モルフォシス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 自己抗体介在性自己免疫疾患の処置のための、抗ｃｄ３８抗体及びその医薬組成物 |
-
2022
- 2022-07-18 TW TW111126828A patent/TW202321303A/zh unknown
- 2022-07-19 EP EP22754062.2A patent/EP4373574A1/en active Pending
- 2022-07-19 MX MX2024000872A patent/MX2024000872A/es unknown
- 2022-07-19 CA CA3225908A patent/CA3225908A1/en active Pending
- 2022-07-19 AU AU2022315512A patent/AU2022315512A1/en active Pending
- 2022-07-19 WO PCT/EP2022/070162 patent/WO2023001804A1/en not_active Ceased
- 2022-07-19 IL IL309940A patent/IL309940A/en unknown
- 2022-07-19 JP JP2024502640A patent/JP2024525870A/ja active Pending
- 2022-07-19 KR KR1020247003421A patent/KR20240035816A/ko active Pending
- 2022-07-19 US US18/580,460 patent/US20240343822A1/en active Pending
-
2024
- 2024-01-17 CL CL2024000146A patent/CL2024000146A1/es unknown
- 2024-11-11 CL CL2024003440A patent/CL2024003440A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022191301A5 (OSRAM) | ||
| JP2022002524A5 (OSRAM) | ||
| JP2021526022A5 (OSRAM) | ||
| JP6278536B2 (ja) | 関節炎治療 | |
| JP2004510752A5 (OSRAM) | ||
| JP2024531151A5 (OSRAM) | ||
| JP2015514110A5 (OSRAM) | ||
| SCHwARz et al. | Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation | |
| JP2025131696A5 (OSRAM) | ||
| JP2023524149A5 (OSRAM) | ||
| JP2023541860A5 (OSRAM) | ||
| RU2010120879A (ru) | Антитела против g-белка распираторно-синцитиального вируса (rsv) | |
| JP2023055904A5 (OSRAM) | ||
| JP2021532126A5 (OSRAM) | ||
| JP2023545520A5 (OSRAM) | ||
| JP2024024114A5 (OSRAM) | ||
| JP2022523372A5 (OSRAM) | ||
| JP2024540148A5 (OSRAM) | ||
| JP2023545183A5 (OSRAM) | ||
| JP2024534602A5 (OSRAM) | ||
| JP2024069230A5 (OSRAM) | ||
| JP2021512652A5 (OSRAM) | ||
| JP2021511024A5 (OSRAM) | ||
| JP2025087764A5 (OSRAM) | ||
| JP2022529929A5 (OSRAM) |